COVID-19

The plan calls for all Americans who received Pfizer/BioNTech and Moderna to obtain a third shot eight months after their second dose.

Merck’s molnupiravir is a twice-daily oral antiviral agent currently under study as a potential treatment for mild/moderate COVID-19.

Personal support workers are at higher risk of contracting the virus compared to physicians, according to the Canadian Institute for Health Information.

Think of the last time you were really afraid—and I mean terrified: Cold sweats, trembling, pounding heart. Now think about what it would be like to have that reaction if you saw a needle or even heard people talking about vaccines.

Several groups are working to get shots to poor countries, but they're falling far short of what's needed to curb outbreaks around the world.

Matshidiso Moeti and other African health officials, including the Africa Centers for Disease Control and Prevention, had warned against booster shots in recent weeks as less than 2% of the population on the continent of 1.3 billion people is fully vaccinated against COVID-19.

The Ontario Medical Association has released a report outlining five core system-level solutions to physician burnout.